Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model

Autor: Toledo, AC, Sakoda, CPP, Perini, A, Pinheiro, NM, Magalhães, RM, Grecco, S, Tibério, IFLC, Câmara, NO, Martins, MA, Lago, JHG, Prado, CM

Asthma is an inflammatory disease that involves airway hyperresponsiveness and remodelling. Flavonoids have been associated to anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment of asthma. Our aim was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::682858730fd6dfe933e49140c72384da
https://europepmc.org/articles/PMC3605879/

Heart failure associated with chronic Chagas cardiomyopathy increases the risk of impaired lung function and reduced submaximal functional capacity.

Autor: da Silva PB; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Diniz CP; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Mediano MFF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil; Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, RJ, Brazil., Mendes FSNS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Reis LFF; Postgraduate Program in Rehabilitation Sciences, Augusto Motta University Center, Rio de Janeiro, RJ, Brazil., Reis MS; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., de Holanda MT; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil., Mazzoli-Rocha F; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: flavia.mazzoli@ini.fiocruz.br., de Sousa AS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Publikováno v: Heart & lung : the journal of critical care [Heart Lung] 2024 Nov 05; Vol. 69, pp. 222-228. Date of Electronic Publication: 2024 Nov 05.

Exploring the Synergistic Secretome: Insights from Co-Cultivation of Aspergillus brasiliensis and Trichoderma reesei RUT-C30.

Autor: Sperandio GB; Laboratory of Enzymology, Department of Cell Biology, University of Brasília, Brasília 70910-900, DF, Brazil., Melo RM; Laboratory of Protein Chemistry and Biochemistry, Department of Cellular Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., Gomes TG; Laboratory of Microbiology, Department of Cell Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., Miller RNG; Laboratory of Microbiology, Department of Cell Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., do Vale LHF; Laboratory of Protein Chemistry and Biochemistry, Department of Cellular Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., Sousa MV; Laboratory of Protein Chemistry and Biochemistry, Department of Cellular Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., Ricart CAO; Laboratory of Protein Chemistry and Biochemistry, Department of Cellular Biology, University of Brasília, Brasilia 70910-900, DF, Brazil., Filho EXF; Laboratory of Enzymology, Department of Cell Biology, University of Brasília, Brasília 70910-900, DF, Brazil.

Publikováno v: Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2024 Sep 28; Vol. 10 (10). Date of Electronic Publication: 2024 Sep 28.

Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.

Autor: Veras VR; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil.; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, CE, Brazil., da Cruz Paiva Lima GE; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; University of Fortaleza, (UNIFOR), Fortaleza, CE, Brazil.; Diagnosticos das Americas DASA, São Paulo, Brazil., da Ponte Melo I; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil.; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, CE, Brazil., Fernandes VO; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil.; Department of Community Health, Federal University of Ceará, Fortaleza, CE, Brazil., de Moura Lopes FK; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil., do Amaral CL; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil., Castelo MHG; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil., Queiroz LL; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil., Araújo JS; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil., Valerio CM; IEDE, Rio de Janeiro, RJ, Brazil., Montenegro Junior RM; Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Fortaleza, CE, Brazil. renanmmjr@gmail.com.; Clinical Research Unit, Walter Cantídio University Hospital, Federal University of Ceará/EBSERH, Fortaleza, CE, Brazil. renanmmjr@gmail.com.; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, CE, Brazil. renanmmjr@gmail.com.; Department of Community Health, Federal University of Ceará, Fortaleza, CE, Brazil. renanmmjr@gmail.com.

Publikováno v: Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2024 Sep 04; Vol. 16 (1), pp. 216. Date of Electronic Publication: 2024 Sep 04.

Physical activity levels during COVID-19 pandemic and its associated factors in patients with Chagas disease.

Autor: Xavier IGG; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Andrade PM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Vitor RL; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Barros TC; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Portela LF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., de Holanda MT; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sangenis LHC; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Sperandio da Silva GM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mazzoli-Rocha F; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mendes FSNS; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Costa AR; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Quintana MSB; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Hasslocher-Moreno AM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Araujo IL; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Junqueira ACV; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinheiro RO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Georg I; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Paravidino VB; Department of Epidemiology, Institute of Social Medicine Hésio Cordeiro, State University of Rio de Janeiro, Rio de Janeiro, Brazil.; Department of Physical Education and Sports, Naval Academy, Brazilian Navy, Rio de Janeiro, Brazil., Gonçalves TR; Institute of Public Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Saraiva RM; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Mediano MFF; Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Department of Research and Education, National Institute of Cardiology, Rio de Janeiro, Brazil.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Aug 06; Vol. 11, pp. 1411977. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).